Filing Details
- Accession Number:
- 0001127602-22-024599
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-01 16:30:40
- Reporting Period:
- 2022-10-28
- Accepted Time:
- 2022-11-01 16:30:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
310158 | Merck & Co. Inc. | MRK | Pharmaceutical Preparations (2834) | 221918501 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1916310 | Jacobus Johannes Oosthuizen | Merck &Amp; Co., Inc. 126 Lincoln Avenue Rahway NJ 07065 | President, U.s. Market | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-10-28 | 3,633 | $100.21 | 10,881 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2022-10-30 | 913 | $100.77 | 11,794 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-10-30 | 450 | $100.77 | 11,344 | No | 4 | F | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Unit | Disposition | 2022-10-30 | 913 | $0.00 | 913 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
915 | 2021-10-30 | 2023-10-30 | No | 4 | M | Direct |
Footnotes
- Holdings include shares acquired in dividend reinvestment transactions.
- Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2021, 10/30/2022 and 10/30/2023.